Home / Companies / Shenzhen Kangtai Biological Products Co., Ltd. / 26 Sep 2023
Shenzhen Kangtai Biological Products Co., Ltd.: meeting of 26 Sep 2023
Votes reported on Form N-PX, item by item
29 Form N-PX filers reported votes at the Shenzhen Kangtai Biological Products Co., Ltd. meeting of 26 Sep 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
4 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
56 vote records from 29 filers. 0 of the 28 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
8 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.
CORPORATE GOVERNANCESecurity holder
Shareholder proposal: CORPORATE GOVERNANCE
49 vote records from 23 filers. 0 of the 22 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Auditor | 4. Proposal |
|---|---|---|
| Vanguard | No report | For |
| BlackRock and iShares | No report | For |
| Fidelity | No report | For |
| Dimensional | No report | For |
| State Street and SPDR | No report | For |
| Franklin Templeton | No report | For |
| Charles Schwab | For | No report |
| Nuveen and TIAA | No report | For |
| Morgan Stanley, Eaton Vance and Calvert | No report | For |
| Northern Trust and FlexShares | No report | For |
| Lincoln Financial | No report | For |
| Voya | No report | For |
| Pacific Life funds | No report | For |
| Global X | For | No report |
| VanEck | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Shenzhen Kangtai Biological Products Co., Ltd. meeting?
29 Form N-PX filers reported votes at the meeting of 26 Sep 2023. One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shenzhen Kangtai Biological Products Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Shenzhen Kangtai Biological Products Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shenzhen Kangtai Biological Products Co., Ltd. with a meeting date within three days of 26 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.